Welcome to CDC stacks | Integrated proteomic and phosphoproteomic analyses of cisplatin-sensitive and resistant bladder cancer cells reveal CDK2 network as a key therapeutic target - 59722 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Integrated proteomic and phosphoproteomic analyses of cisplatin-sensitive and resistant bladder cancer cells reveal CDK2 network as a key therapeutic target
  • Published Date:
    Aug 24 2018
  • Source:
    Cancer Lett. 437:1-12.
  • Language:
    English


Public Access Version Available on: November 28, 2019 information icon
Please check back on the date listed above.
Details:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like: